- News & Analysis
- Home
- Latest News
- Reports
- Podcasts
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Sectors
Repare rounds off $253m initial public offering
Celgene Switzerland and BMS-backed precision cancer drug developer Repare Therapeutics added $33m to its IPO after its shares rose 65% post-offering.
Jun 24, 2020Xavier cashes in acquisition cheque
Receipt Bank has purchased Xavier Analytics, a portfolio company of SETsquared Bristol.
Jun 24, 2020nCino enters IPO stage
The Salesforce-backed banking platform developer has filed for a $100m initial public offering having raised $80m late last year.
Jun 24, 2020Microsoft snags CyberX in $165m acquisition
The IoT security technology provider had raised $48m in funding from investors including Qualcomm and Čez pre-acquisition.
Jun 24, 2020Urjanet bills Equifax in series D round
Equifax was among the investors that provided $14.7m for the utility customer data provider to push its total funding past the $40m mark.
Jun 24, 2020Foldax packs up $20m
MemorialCare Innovation Fund contributed to a series D round that brought the heart valve technology developer's overall funding to more than $36m.
Jun 23, 2020VisionNav lifts series B1 funding
Corporate venturing unit Lenovo Capital led a round that boosted smart forklift developer VisionNav’s funding total to more than $18m.
Jun 23, 2020Foldax packs up $20m
MemorialCare Innovation Fund contributed to a series D round that brought the Caltech spinout's overall funding to more than $36m.
Jun 23, 2020VisionNav lifts series B1 funding
Smart forklift developer VisionNav has now collected more than $18m altogether to advance work from Chinese University of Hong Kong and University of Tokyo.
Jun 23, 2020Surrozen scurries to $50m series C
Hartford Healthcare returned for a $50m series C round that will support the Stanford spinout in advancing potential treatments for severe liver and inflammatory bowel diseases.
Jun 23, 2020Daily deal net: June 23, 2020
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Jun 23, 2020Invitae to inhale ArcherDX in $1.4bn deal
The Qiagen-founded precision cancer technology provider agreed to an acquisition by Invitae sized at at least $325m in cash and shares currently valued at about $820m.
Jun 23, 2020Featured Content
GCVI Summit 2026 RewindRewatch the sessions, recap the learningsGCVI Summit 2026 Rewind
Rewatch the sessions, recap the learnings
The World of Corporate VenturingGCV's annual report on the state of the corporate investment sectorThe World of Corporate Venturing
GCV's annual report on the state of the corporate investment sector
GCV’s Rising Stars and Emerging Leaders 2026The talent pipeline in corporate venturing shows both momentum and staying power, as the industry comes of age.GCV’s Rising Stars and Emerging Leaders 2026
The talent pipeline in corporate venturing shows both momentum and staying power, as the industry comes of age.
About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation


